Real world experience with minimally invasive wireless percutaneous neuromodulation in a tertiary care centre

Abstract

Background

Wireless percutaneous nerve stimulation (PNS) for chronic pain is rapidly evolving in the ever expanding neuromodulation paradigm. Safety and lower risks with a potential of long-term analgesia cannot be over emphasised especially with the ongoing opioid pandemic. PNS with an implanted pulse generator (IPG) has also been shown to provide good benefit, without often unpleasant widespread paraesthesia from conventional spinal cord stimulators.

Aim and Methods

We retrospectively extracted data on all wireless PNS implants in our highly specialised pain neuromodulation centre since initiation of wireless PNS service in August 2019. Patient demographics, pain history, analgesic intake and details on implant follow-up data within 1 year post-implant including pain relief, EuroQol-5 Dimension (EQ-5D) and Patients’ Global Impression of Change (PGIC) scores were extracted. The cases are presented in a narrative format.

Result

A total of five patients were implanted with wireless (Stimwave^®) PNS from August 2019 to February 2020. Neuropathic pain was the most common presenting diagnosis. All patients showed >50% pain relief at 3 months. EQ-5D and PGIC did not show any improvement in the subjects. Two of the patients managed to decrease their analgesics after implantation. Similar sustained benefits could not be demonstrated after 1 year.

Discussion

PNS can provide analgesia in appropriately selected cases. Naivety of the technique and procedure might cause some degree of uncertainty. External pulse generator with wireless transmission avoids IPG and tunnelling related side effects, but requires individualised special wearable technology to power the lead. Minimally invasive nature of the technique might be attractive and preferable for patients with complex medical issues, nickel allergy and poor general health who may otherwise be unsuitable for Spinal Cord Stimulation (SCS) with conventional hardware. Robust prospective controlled studies and RCTs in future might provide further insights on utility in other neuropathic pain diagnosis, long-term outcomes and acceptability compared to conventional SCS.

Keywords

Wireless neuromodulation minimally invasive peripheral nerve stimulation craniofacial pain neuropathy post-surgical pain

Get full access to this article

View all access options for this article.

References

Verrills

Vivian

Mitchell

, et al. Peripheral nerve field stimulation for chronic pain: 100 cases and review of the literature. Pain Med 2011; 12: 1395–1405.

Slavin

. History of peripheral nerve stimulation. Prog Neurol Surg 2011; 24: 1–15.

Melzack

Wall

. Pain mechanisms: a new theory. Science 1965; 150: 971–979.

Eldabe

Buchser

Duarte

. Complications of spinal cord stimulation and peripheral nerve stimulation techniques: a review of the literature. Pain Med 2016; 17: 325–336.

Billet

Wynendaele

Vanquathem

. A novel minimally invasive wireless technology for neuromodulation via percutaneous intercostal nerve stimulation for post-herpetic neuralgia: a case report with short-term follow-up. Pain Pract 2018; 18: 374–379.

Nayak

Banik

. Current innovations in peripheral nerve stimulation. Pain Res Treat 2018; 2018: 9091216.

Shaparin

Gritsenko

Garcia-Roves

, et al. Peripheral neuromodulation for the treatment of refractory trigeminal neuralgia. Pain Res Manag 2015; 20: 63–66.

Goyal

Gupta

Jain

, et al. Peripheral nerve field stimulation for intractable post-thoracotomy scar pain not relieved by conventional treatment. Pain Pract 2010; 10: 366–369.

Slavin

. Technical aspects of peripheral nerve stimulation: hardware and complications. Prog Neurol Surg 2011; 24: 189–202.

10.

Sator-Katzenschlager

Fiala

Kress

, et al. Subcutaneous target stimulation (STS) in chronic noncancer pain: a nationwide retrospective study. Pain Pract 2010; 10(4): 279–286.

11.

Bolash

Creamer

Rauck

, et al. Wireless high-frequency spinal cord stimulation (10 KHZ) compared with multiwaveform low-frequency spinal cord stimulation in the management of chronic pain in failed back surgery syndrome subjects: preliminary results of a multicenter, prospective randomized controlled study. Pain Med 2019; 20: 1971–1979.